ALFA Filings
Every announcement, straight from the exchange
Every Brooks Laboratories merger & restructuring announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Brooks Laboratories approved a demerger of its Manufacturing Business into its wholly-owned subsidiary, Abridge Speciality Limited, through a scheme of arrangement.
Brooks Laboratories signed a binding MoU to sell a portion of its Brooks Steriscience stake. The deal provides Rs.106.33 Crore cash inflow and retains 32.67% equity.
Brooks Laboratories Ltd incorporated a wholly owned subsidiary, Abridge Speciality Limited. This strategic move aims to expand its pharmaceutical business operations.